Skip to content
Assyro AI

Title f-27 LAWS reference

Explore the full hierarchy of this title across chapters, subchapters, and parts.

Select a part from the tree to begin

Browse chapters and parts on the left to load sections

CANADA • Title f-27 Laws • Part 11.1

Part 11.1 — Risk to environment

This section prohibits the sale, manufacture, preparation, preservation, packaging, or storage for sale of any drug containing a prescribed substance, unless the Minister has conducted an environmental risk assessment for that substance.

What this part covers

  • A person is prohibited from selling any drug that contains a prescribed substance unless the Minister has conducted an environmental risk assessment.
  • A person is prohibited from manufacturing any drug that contains a prescribed substance unless the Minister has conducted an environmental risk assessment.
  • A person is prohibited from preparing any drug that contains a prescribed substance unless the Minister has conducted an environmental risk assessment.
  • A person is prohibited from preserving any drug that contains a prescribed substance unless the Minister has conducted an environmental risk assessment.
  • A person is prohibited from packaging any drug that contains a prescribed substance unless the Minister has conducted an environmental risk assessment.
  • A person is prohibited from storing for sale any drug that contains a prescribed substance unless the Minister has conducted an environmental risk assessment.

Sections in Part 11.1

Regulatory Context

This document sits within CANADA Laws and is most useful when linked to operational submission, quality, and inspection workflows.

CANADALaws

Related Terms

Operational Use Cases

Related Actions